尖酸好
发表于 2025-3-21 16:17:56
书目名称Non-Hodgkin Lymphoma影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0666922<br><br> <br><br>书目名称Non-Hodgkin Lymphoma影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0666922<br><br> <br><br>书目名称Non-Hodgkin Lymphoma网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0666922<br><br> <br><br>书目名称Non-Hodgkin Lymphoma网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0666922<br><br> <br><br>书目名称Non-Hodgkin Lymphoma被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0666922<br><br> <br><br>书目名称Non-Hodgkin Lymphoma被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0666922<br><br> <br><br>书目名称Non-Hodgkin Lymphoma年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0666922<br><br> <br><br>书目名称Non-Hodgkin Lymphoma年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0666922<br><br> <br><br>书目名称Non-Hodgkin Lymphoma读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0666922<br><br> <br><br>书目名称Non-Hodgkin Lymphoma读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0666922<br><br> <br><br>
初学者
发表于 2025-3-21 21:32:32
Book 2015in lymphoma, taking into account the significant growth in knowledge including multiple therapeutic advances that have been achieved over the past 5-10 years. The work is subdivided into epidemiology, pathogenesis, pathology, imaging, and therapy of the non-Hodgkin lymphomas. The full range of thera
municipality
发表于 2025-3-22 01:38:27
Epidemiology and Etiology of Non-Hodgkin Lymphoma,of lymphomagenesis, but significant etiologic heterogeneity clearly exists. This review presents a summary of the current understanding of the descriptive epidemiology and etiology of NHL and suggests areas of focus for future epidemiologic research.
callous
发表于 2025-3-22 05:42:05
http://reply.papertrans.cn/67/6670/666922/666922_4.png
PATRI
发表于 2025-3-22 09:33:50
http://reply.papertrans.cn/67/6670/666922/666922_5.png
拍翅
发表于 2025-3-22 15:15:33
Current Management of Peripheral T-Cell Lymphomas,rs, aurora kinase inhibitors and the CD30 antibody-drug conjugate brentuximab vedotin, have shown promise in the treatment of PTCLs. Studies are underway to explore the activity of these newer agents used in the frontline setting.
Congregate
发表于 2025-3-22 17:22:51
Book 2015peutic options are examined according to the major subtypes of non-Hodgkin lymphoma and the most up-to-date information is provided on current standard treatment options, including stem cell transplantation as well as new cutting-edge therapeutics.
CLEAR
发表于 2025-3-23 00:13:51
http://reply.papertrans.cn/67/6670/666922/666922_8.png
说笑
发表于 2025-3-23 01:30:46
http://reply.papertrans.cn/67/6670/666922/666922_9.png
Airtight
发表于 2025-3-23 08:56:03
http://reply.papertrans.cn/67/6670/666922/666922_10.png